VXRT(Vaxart, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $892.00K | $107.00K | $7.38M | $28.70M | $237.26M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$72.75M | −$114.59M | −$83.35M | −$66.29M | $18.07M |
| 净利润 | −$70.47M | −$107.76M | −$82.47M | −$66.95M | $16.33M |
| 经营现金流 | −$59.83M | −$94.78M | −$70.45M | −$44.76M | $7.71M |
| 自由现金流 | −$64.99M | −$104.38M | −$72.32M | −$45.32M | $7.57M |
| 摊薄每股收益 | $-0.58 | — | — | $-0.33 | $0.07 |